News

Updated Guidelines for Management of Thyroid Disease in Adults

Thyroidectomy is a commonly performed surgical procedure for the partial/complete removal of the thyroid gland. According to the United states data, over 100,000 thyroid operations are performed annually in the US alone. In order to have a uniform and evidence-based treatment for the management of thyroid disease, various guidelines are published by different surgical associations.

Clinical Practice Guideline on Management of Nose Bleed (Epistaxis)

Nose bleed or Epistaxis is a common clinical condition that occurs at some point in at least 60% of people in the United States. While the majority of nosebleeds are limited in severity and duration, about 6% of people need medical attention for control of nose bleed. Overall 0.5% of all emergency department visits and

Middle Ear Hearing Implants – An Overview

Middle ear hearing implants belongs to the group of Implantable Acoustics or Mechanical hearing devices which are used in rehabilitative management of patients with hearing loss, offering an alternative to conventional hearing aids. The first clinically available Middle ear hearing implant was designed by Drs. Suzuki and Yanagihara in Japan for patients with irreversible middle

Radiotherapy is better than TORS for Oropharyngeal Cancers – ORATOR Says

The mainstay of treatment for oropharyngeal squamous cell carcinoma is chemoradiotherapy. The separation of oropharyngeal cancers into Human papillomavirus (HPV) positive and negative based on the etiology has shown that HPV positive cancers have a better prognosis and survival compared to HPV negative cancers. These young age HPV positive patients with prolonged survival are more

Ultrasound Otoscopes For Aiding Diagnosis Of Middle Ear Infections

Middle ear infections are one of the most common problems for a clinical visit to an otolaryngologist. The disease is more prevalent in pediatric populations but can affect any age group. The most common presentation is Otitis Media with Effusion/OME (i.e fluid collecting in the middle ear behind an intact tympanic membrane /eardrum). This fluid

FDA Approves Cochlear Implants for Asymmetric, Single-Sided Deafness

Cochlear implants are electronic prosthetic devices used in adults and children with sensory neural hearing loss, who are not benefited by the use of conventional hearing aids. Unlike hearing aids, which make sounds louder, cochlear implants work by turning sound into electrical signals and then directly stimulate the hearing nerves. Single-sided deafness (SSD) or asymmetric hearing

Sudden Hearing Loss: Updated Clinical Practice Guideline

Sudden hearing loss (SHL), defined as a rapid-onset subjective sensation of hearing impairment in one or both ears is an emergency in the ear-nose-throat clinical practice. If not recognized and managed promptly, sudden hearing loss may result in persistent hearing loss and tinnitus and reduced patient quality of life. The disease affects 5 to 27

FDA approves Dupixent (dupilumab) as treatment for chronic rhinosinusitis

Chronic rhinosinusitis (CRS) is a clinical condition characterized by prolonged inflammation (more than 12 weeks) of the nose and paranasal sinuses. Signs and symptoms of sinusitis include headache, swelling of face, facial pain, nasal discharge, dizziness, and breathing difficulties. Sinusitis is caused by allergies, bacterial and viral infections and presence of nasal polyps (growths on

NICE guidelines for Cochlear implantation in children and adults

The National Institute for Health and Care Excellence (NICE) is a non-departmental public body in England, that provides national guidance and advice to improve health and social care. On 7th March 2019, NICE released an update for the 2009 cochlear implantation guidelines in children and adults with hearing loss. Cochlear implants are electronic prosthetic devices

World Hearing Day

Globally it is estimated that over 5% of the world’s population i.e around 466 million people – have disabling hearing loss (432 million adults and 34 million children). Unaddressed hearing loss is the leading cause of morbidity and poses an annual cost of $750 billion globally. It is estimated that by 2050 over 900 million